Refissa (Emolient Retin A - 0.5%)

Refissa, a new topical formulation of Tretinoin, has been approved by the U.S. Food and Drug Administration (FDA). Refissa is the only 0.05% prescription strength, fragrance-free, emollient-based Tretinoin Cream specifically indicated for dry skin. Among topical retinoids, Tretinoin is the gold standard of treatments, and Refissa, formulated in a moisturizing base, is an ideal option for mature patients with drier photo damaged skin or people with normal to dry skin. Refissa contains tretinoin, a derivative of vitamin A, and works deep at the skin's cellular level to increase collagen, which the body produces less of with age. Refissa has been proven in a clinical trial to be effective in the treatment of fine facial wrinkles, tactile roughness of the skin, as well as irregular pigmentation from the sun.

• Refissa is an emollient and fragrance-free Tretinoin 0.05% Cream designed for your Adult Dry Skin patient type.
• Refissa is specifically formulated for dryer more sensitive adult skin. It is the only prescription retinoid that has it all.
• Refissa has been shown in clinical trials to be less irritating at weeks 2 and 24.
• 71% of women saw improvement in their fine facial wrinkles and 83% saw improvement in irregular pigmentation.
• Compared to Renova .05%.